Absence of gallium uptake in unicentric and multicentric Castleman's disease

被引:7
作者
Okamoto, I
Iyonaga, K
Fujii, K
Mori, T
Yoshioka, M
Kohrogi, H
Matsumoto, M
Suga, M
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Resp Med, Kumamoto 8600811, Japan
[2] Kumamoto Univ, Grad Sch Med Sci, Dept Surg 1, Kumamoto, Japan
关键词
Castleman's disease; lymphoproliferative disorders; Ga-67; scintigraphy;
D O I
10.2169/internalmedicine.42.735
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Castleman's disease is a rare and poorly understood condition involving lymph nodes at various sites, predominantly in the mediastinum. Individuals with this disease often present with lymphadenopathy and general symptoms suggestive of lymphomatous disease, and they are at risk of developing malignant lymphoma. It is thus important to distinguish Castleman's disease from other lymphoproliferative disorders. Ga-67 scintigraphy is a non-invasive and practical diagnostic tool for the investigation of patients with lymphoproliferative disorders. However, the value of this technique for the diagnosis of Castleman's disease is not clear. Here, we describe five consecutive patients with various types of Castleman's disease and show that none of these individuals exhibited Ga-67 uptake. Our results suggest the potential value of Ga-67 scintigraphy in both the diagnosis and management of Castleman's disease.
引用
收藏
页码:735 / 739
页数:5
相关论文
共 21 条
[1]  
Bowne WB, 1999, CANCER, V85, P706, DOI 10.1002/(SICI)1097-0142(19990201)85:3<706::AID-CNCR21>3.0.CO
[2]  
2-7
[3]  
CASTLEMAN B, 1956, CANCER, V9, P822, DOI 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO
[4]  
2-4
[5]  
Chim CS, 2001, HAEMATOLOGICA, V86, P442
[6]  
Chronowski M, 2001, CANCER, V92, P670
[7]  
Gessain A, 1996, BLOOD, V87, P414
[8]  
KELLER AR, 1972, CANCER-AM CANCER SOC, V29, P670, DOI 10.1002/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO
[9]  
2-#
[10]   Castleman disease in the anterior neck: The role of Ga-67 scintigraphy [J].
Kinoshita, T ;
Ishii, K ;
Mori, Y ;
Naganuma, H .
CLINICAL NUCLEAR MEDICINE, 1996, 21 (08) :626-628